Willow Review
Premium GLP-1 clinic with a needle-free sublingual semaglutide tablet option.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Quick Verdict
A premium-priced clinic that earns its rate through the sublingual tablet option and unlimited messaging. Most buyers can find compounded injections cheaper elsewhere. Most buyers can find compounded GLP-1 for less elsewhere; Willow's premium is justified primarily by the sublingual tablet option and the unlimited messaging model.
- Sublingual semaglutide tablets are rare
- Same-day approval and two-day shipping
- Unlimited physician messaging
- Highest monthly entry price in the category
- Compounded only, no brand-name option
- Sublingual GLP-1 absorption is less validated than injection
Willow Pricing
Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at Willow.
| Program / Membership Fee | Included in monthly plan |
| Medication Cost (From) | From $299 – $549/mo |
Willow bundles physician oversight, medication, free two-day shipping, and unlimited messaging into one premium monthly fee. There is no brand-name medication option and no insurance billing.
Who Willow Is For
Willow is best suited to readers who specifically want a sublingual semaglutide tablet alternative to injections and are willing to pay a premium monthly rate for unlimited physician access and two-day shipping. The sublingual tablet option is the clearest differentiator — it is one of the few telehealth platforms that offers oral semaglutide as a primary delivery format rather than an add-on.
Needle-averse adults who want a premium-priced GLP-1 program with sublingual semaglutide tablets and unlimited physician access.
Signature Programs
- ›Compounded semaglutide injection
- ›Sublingual semaglutide tablets
- ›Compounded tirzepatide injection
Medication Formulary
How Willow Scores
Willow scores 4.0 / 5 overall (cost 3.8, experience 4.4, trust 4.1), which makes it one of the specialty options in the GLP-1 weight loss category we cover.
See how Willow compares in our full GLP-1 weight loss rankings, or read the Best Telehealth GLP-1 Providers guide. Our methodology explains how we score each provider.
Frequently Asked Questions
How much does Willow cost per month?
Willow's published pricing runs $299 to $549 per month. Willow bundles physician oversight, medication, free two-day shipping, and unlimited messaging into one premium monthly fee. There is no brand-name medication option and no insurance billing. Confirm the all-in monthly total at checkout, because telehealth pricing changes without notice.
Does Willow charge more as your GLP-1 dose increases?
Willow publishes a bundled monthly price ($299 to $549 per month). The top of that range generally reflects higher doses or brand-name options, so check which tier your maintenance dose falls into.
What medications does Willow prescribe?
Willow lists compounded semaglutide, compounded sublingual semaglutide, compounded semaglutide tablets, among others. It focuses on compounded medications rather than FDA-approved brand-name drugs. What you are prescribed depends on the clinician's assessment and your state.
Is Willow legit?
Willow connects patients with licensed clinicians for GLP-1 weight loss care. At our last check it held a 3.9/5 Trustpilot rating from 359 reviews. We score its trust and transparency at 4.1/5. Before ordering, check that the clinician is licensed in your state and, for compounded drugs, which pharmacy fills the prescription.
Can I cancel Willow anytime?
Most telehealth plans, Willow's included, are cancelled through the patient portal or support team, but refund terms vary. Compounded medication is made to order, so shipments are usually non-refundable once dispensed. Read the current terms before your first refill date to avoid an unwanted renewal.
- Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
- Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss vs 3.1% placebo at 72 weeks in SURMOUNT-1.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.
Alternatives To Willow
Also Competes With
Willow also operates in Longevity & NAD+. Here are other providers in those spaces: